<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31061163</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-6596</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Antimicrobial agents and chemotherapy</Title><ISOAbbreviation>Antimicrob Agents Chemother</ISOAbbreviation></Journal><ArticleTitle>Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00397-19</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/AAC.00397-19</ELocationID><Abstract><AbstractText>Dengue virus (DENV) and Japanese encephalitis virus (JEV) are important arthropod-borne viruses from the <i>Flaviviridae</i> family. DENV is a global public health problem with significant social and economic impacts, especially in tropical and subtropical areas. JEV is a neurotropic arbovirus endemic to east and southeast Asia. There are no U.S. FDA-approved antiviral drugs available to treat or to prevent DENV and JEV infections, leaving nearly one-third of the world's population at risk for infection. Therefore, it is crucial to discover potent antiviral agents against these viruses. Nucleoside analogs, as a class, are widely used for the treatment of viral infections. In this study, we discovered nucleoside analogs that possess potent and selective anti-JEV and anti-DENV activities across all serotypes in cell-based assay systems. Both viruses were susceptible to sugar-substituted 2'-<i>C</i>-methyl analogs with either cytosine or 7-deaza-7-fluoro-adenine nucleobases. Mouse studies confirmed the anti-DENV activity of these nucleoside analogs. Molecular models were assembled for DENV serotype 2 (DENV-2) and JEV RNA-dependent RNA polymerase replication complexes bound to nucleotide inhibitors. These models show similarities between JEV and DENV-2, which recognize the same nucleotide inhibitors. Collectively, our findings provide promising compounds and a structural rationale for the development of direct-acting antiviral agents with dual activity against JEV and DENV infections.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zandi</LastName><ForeName>Keivan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tropical Infectious Disease Research and Education Center, Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassit</LastName><ForeName>Leda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amblard</LastName><ForeName>Franck</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Bryan D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassandarvish</LastName><ForeName>Pouya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Tropical Infectious Disease Research and Education Center, Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghaddam</LastName><ForeName>Ehsan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Tropical Infectious Disease Research and Education Center, Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yueh</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Libanio Rodrigues</LastName><ForeName>Gisele Olinto</ForeName><Initials>GO</Initials><AffiliationInfo><Affiliation>Center for Research and Drug Development, Instituto de Ciencias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passos</LastName><ForeName>Ingredy</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Research and Drug Development, Instituto de Ciencias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Vivian V</ForeName><Initials>VV</Initials><AffiliationInfo><Affiliation>Center for Research and Drug Development, Instituto de Ciencias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AbuBakar</LastName><ForeName>Sazaly</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tropical Infectious Disease Research and Education Center, Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Longhu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohler</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Mauro M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Drug Development, Instituto de Ciencias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schinazi</LastName><ForeName>Raymond F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA rschina@emory.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AI050409</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI129607</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Antimicrob Agents Chemother</MedlineTA><NlmUniqueID>0315061</NlmUniqueID><ISSNLinking>0066-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009705">Nucleosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018349" MajorTopicYN="N">Encephalitis Viruses, Japanese</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004671" MajorTopicYN="N">Encephalitis, Arbovirus</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009705" MajorTopicYN="N">Nucleosides</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012324" MajorTopicYN="N">RNA-Dependent RNA Polymerase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dengue virus</Keyword><Keyword MajorTopicYN="N">Japanese encephalitis virus</Keyword><Keyword MajorTopicYN="N">antiviral agents</Keyword><Keyword MajorTopicYN="N">nucleoside analogs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31061163</ArticleId><ArticleId IdType="pmc">PMC6591611</ArticleId><ArticleId IdType="doi">10.1128/AAC.00397-19</ArticleId><ArticleId IdType="pii">AAC.00397-19</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Messina JP, Brady OJ, Scott TW, Zou C, Pigott DM, Duda KA, Bhatt S, Katzelnick L, Howes RE, Battle KE, Simmons CP, Hay SI. 2014. Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol 22:138&#x2013;146. doi:10.1016/j.tim.2013.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2013.12.011</ArticleId><ArticleId IdType="pmc">PMC3946041</ArticleId><ArticleId IdType="pubmed">24468533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler DJ, Ooi EE, Vasudevan S, Farrar J (eds). 2014. Dengue and dengue hemorrhagic fever, 2nd ed CABI, Wallingford, UK.</Citation></Reference><Reference><Citation>Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Mart&#xed;nez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW. 2010. Dengue: a continuing global threat. Nat Rev Microbiol 8:S7&#x2013;S16. doi:10.1038/nrmicro2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Liang G. 2015. Epidemiology of Japanese encephalitis: past, present, and future prospects. Ther Clin Risk Manag 11:435. doi:10.2147/TCRM.S51168.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S51168</ArticleId><ArticleId IdType="pmc">PMC4373597</ArticleId><ArticleId IdType="pubmed">25848290</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul W, Moore P, Karabatsos N, Flood S, Yamada S, Jackson T, Tsai T. 1993. Outbreak of Japanese encephalitis on the island of Saipan, 1990. J Infect Dis 167:1053&#x2013;1058. doi:10.1093/infdis/167.5.1053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/167.5.1053</ArticleId><ArticleId IdType="pubmed">8387561</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakai S. 1998. Scourge of Japanese encephalitis in south-western Nepal. Lancet 351:759. doi:10.1016/S0140-6736(05)78540-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)78540-8</ArticleId><ArticleId IdType="pubmed">9504555</ArticleId></ArticleIdList></Reference><Reference><Citation>Unni SK, R&#x16f;&#x17e;ek D, Chhatbar C, Mishra R, Johri MK, Singh SK. 2011. Japanese encephalitis virus: from genome to infectome. Microbes Infect 13:312&#x2013;321. doi:10.1016/j.micinf.2011.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2011.01.002</ArticleId><ArticleId IdType="pubmed">21238600</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT. 2000. Japanese encephalitis. J Neurol Neurosurg Psychiatry 68:405&#x2013;415. doi:10.1136/jnnp.68.4.405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.68.4.405</ArticleId><ArticleId IdType="pmc">PMC1736874</ArticleId><ArticleId IdType="pubmed">10727474</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennessy S, Strom BL, Bilker WB, Zhengle L, Chao-Min W, Hui-Lian L, Tai-Xiang W, Hong-Ji Y, Qi-Mau L, Tsai TF, Karabatsos N, Strom BL, Halstead SB. 1996. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 347:1583&#x2013;1586. doi:10.1016/S0140-6736(96)91075-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)91075-2</ArticleId><ArticleId IdType="pubmed">8667866</ArticleId></ArticleIdList></Reference><Reference><Citation>Dans AL, Dans LF, Lansang MAD, Silvestre MAA, Guyatt GH. 2018. Review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs. J Clin Epidemiol 95:137&#x2013;139. doi:10.1016/j.jclinepi.2017.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2017.11.019</ArticleId><ArticleId IdType="pubmed">29180056</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady D, Thomas K. 
17
December
2017. 
Drug company under fire after revealing dengue vaccine may harm some. New York Times, New York, NY
https://www.nytimes.com/2017/12/17/health/sanofi-dengue-vaccine-philippines.html.</Citation></Reference><Reference><Citation>Bhatia HK, Singh H, Grewal N, Natt NK. 2014. Sofosbuvir: a novel treatment option for chronic hepatitis C infection. J Pharmacol Pharmacother 5:278. doi:10.4103/0976-500X.142464.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0976-500X.142464</ArticleId><ArticleId IdType="pmc">PMC4231565</ArticleId><ArticleId IdType="pubmed">25422576</ArticleId></ArticleIdList></Reference><Reference><Citation>Schinazi RF. 2003. Emtricitabine: a viewpoint. Drugs 63:2425&#x2013;2426. doi:10.2165/00003495-200363220-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-200363220-00004</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawlinson SM, Pryor MJ, Wright PJ, Jans DA. 2006. Dengue virus RNA polymerase NS5: a potential therapeutic target? Curr Drug Targets 7:1623&#x2013;1638. doi:10.2174/138945006779025383.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138945006779025383</ArticleId><ArticleId IdType="pubmed">17168837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SP, Noble CG, Shi P-Y. 2015. The dengue virus NS5 protein as a target for drug discovery. Antiviral Res 119:57&#x2013;67. doi:10.1016/j.antiviral.2015.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.04.010</ArticleId><ArticleId IdType="pubmed">25912817</ArticleId></ArticleIdList></Reference><Reference><Citation>Appleby TC, Perry JK, Murakami E, Barauskas O, Feng J, Cho A, Fox D, Wetmore DR, McGrath ME, Ray AS, Sofia MJ, Swaminathan S, Edwards TE. 2015. Structural basis for RNA replication by the hepatitis C virus polymerase. Science 347:771&#x2013;775. doi:10.1126/science.1259210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1259210</ArticleId><ArticleId IdType="pubmed">25678663</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G, Gong P. 2013. Crystal structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface. PLoS Pathog 9:e1003549. doi:10.1371/journal.ppat.1003549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003549</ArticleId><ArticleId IdType="pmc">PMC3738499</ArticleId><ArticleId IdType="pubmed">23950717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SP, Noble CG, Seh CC, Soh TS, El Sahili A, Chan GKY, Lescar J, Arora R, Benson T, Nilar S, Manjunatha U, Wan KF, Dong H, Xie X, Shi P-Y, Yokokawa F. 2016. Potent allosteric dengue virus NS5 polymerase inhibitors: mechanism of action and resistance profiling. PLoS Pathog 12:e1005737. doi:10.1371/journal.ppat.1005737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005737</ArticleId><ArticleId IdType="pmc">PMC4976923</ArticleId><ArticleId IdType="pubmed">27500641</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa VV, Fagundes CT, Valad&#xe3;o DF, Cisalpino D, Dias ACF, Silveira KD, Kangussu LM, &#xc1;vila TV, Bonfim MRQ, Bonaventura D, Silva TA, Sousa LP, Rachid MA, Vieira LQ, Menezes GB, de Paula AM, Atrasheuskaya A, Ignatyev G, Teixeira MM, Souza DG. 2012. A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-&#x3b3; in host resistance to infection. PLoS Negl Trop Dis 6:e1663. doi:10.1371/journal.pntd.0001663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001663</ArticleId><ArticleId IdType="pmc">PMC3362616</ArticleId><ArticleId IdType="pubmed">22666512</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagundes CT, Costa VV, Cisalpino D, Amaral FA, Souza PRS, Souza RS, Ryffel B, Vieira LQ, Silva TA, Atrasheuskaya A, Ignatyev G, Sousa LP, Souza DG, Teixeira MM. 2011. IFN-&#x3b3; production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner. PLoS Negl Trop Dis 5:e1449. doi:10.1371/journal.pntd.0001449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001449</ArticleId><ArticleId IdType="pmc">PMC3243710</ArticleId><ArticleId IdType="pubmed">22206036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojha A, Nandi D, Batra H, Singhal R, Annarapu GK, Bhattacharyya S, Seth T, Dar L, Medigeshi GR, Vrati S, Vikram NK, Guchhait P. 2017. Platelet activation determines the severity of thrombocytopenia in dengue infection. Sci Rep 7:41697. doi:10.1038/srep41697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41697</ArticleId><ArticleId IdType="pmc">PMC5282509</ArticleId><ArticleId IdType="pubmed">28139770</ArticleId></ArticleIdList></Reference><Reference><Citation>Schexneider K, Reedy E. 2005. Thrombocytopenia in dengue fever. Curr Hematol Rep 4:145&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">15720964</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa VV, Ye W, Chen Q, Teixeira MM, Preiser P, Ooi EE, Chen J. 2017. Dengue virus-infected dendritic cells, but not monocytes, activate natural killer cells through a contact-dependent mechanism involving adhesion molecules. mBio 8:e00741-17. doi:10.1128/mBio.00741-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00741-17</ArticleId><ArticleId IdType="pmc">PMC5539423</ArticleId><ArticleId IdType="pubmed">28765218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler JJ, Nettles JH, Amblard F, Hurwitz SJ, Bassit L, Stanton RA, Ehteshami M, Schinazi RF. 2014. Approaches to hepatitis C treatment and cure using NS5A inhibitors. Infect Drug Resist 7:41. doi:10.2147/IDR.S36247.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S36247</ArticleId><ArticleId IdType="pmc">PMC3949698</ArticleId><ArticleId IdType="pubmed">24623983</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll SS, Olsen D. 2006. Nucleoside analog inhibitors of hepatitis C virus replication. Infect Disord Drug Targets 6:17&#x2013;29. doi:10.2174/187152606776056698.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152606776056698</ArticleId><ArticleId IdType="pubmed">16787301</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox BD, Stanton RA, Schinazi RF. 2015. Predicting Zika virus structural biology: challenges and opportunities for intervention. Antivir Chem Chemother 24:118&#x2013;126. doi:10.1177/2040206616653873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2040206616653873</ArticleId><ArticleId IdType="pmc">PMC5890524</ArticleId><ArticleId IdType="pubmed">27296393</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. 2007. Dengue. Lancet 370:1644&#x2013;1652. doi:10.1016/S0140-6736(07)61687-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61687-0</ArticleId><ArticleId IdType="pubmed">17993365</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A, Hammond SN, P&#xe9;rez L, Tellez Y, Sabor&#xed;o SI, Mercado JC, Cuadra R, Rocha J, P&#xe9;rez MA, Silva S, Rocha C, Harris E. 2006. Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 74:449&#x2013;456. doi:10.4269/ajtmh.2006.74.449.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2006.74.449</ArticleId><ArticleId IdType="pubmed">16525106</ArticleId></ArticleIdList></Reference><Reference><Citation>Rondla R, Coats SJ, McBrayer TR, Grier J, Johns M, Tharnish PM, Whitaker T, Zhou L, Schinazi RF. 2009. Anti-hepatitis C virus activity of novel &#x3b2;-D-2&#x2032;-C-methyl-4&#x2032;-azido pyrimidine nucleoside phosphoramidate prodrugs. Antivir Chem Chemother 20:99&#x2013;106. doi:10.3851/IMP1400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP1400</ArticleId><ArticleId IdType="pmc">PMC7732023</ArticleId><ArticleId IdType="pubmed">19843980</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandelwal RK. 2017. Effect of dengue fever on the total leucocyte count and neutrophil count in children in early febrile period. Int J Pediatr Res 4:617&#x2013;622.</Citation></Reference><Reference><Citation>Madi D, Achappa B, Ramapuram JT, Chowta N, Laxman M, Mahalingam S. 2014. Dengue encephalitis: a rare manifestation of dengue fever. Asian Pac J Trop Biomed 4(Suppl):S70&#x2013;S72. doi:10.12980/APJTB.4.2014C1006.</Citation><ArticleIdList><ArticleId IdType="doi">10.12980/APJTB.4.2014C1006</ArticleId><ArticleId IdType="pmc">PMC4025291</ArticleId><ArticleId IdType="pubmed">25183150</ArticleId></ArticleIdList></Reference><Reference><Citation>Balda&#xe7;ara L, Ferreira JR, Filho LCPS, Venturini RR, Coutinho OMVC, Camar&#xe7;o WC, Fernandes CC, J&#xfa;nior EV. 2013. Behavior disorder after encephalitis caused by dengue. J Neuropsychiatry Clin Neurosci 25:E44. doi:10.1176/appi.neuropsych.12020040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.12020040</ArticleId><ArticleId IdType="pubmed">23487229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-C, Tseng C-K, Wu Y-H, Kaushik-Basu N, Lin C-K, Chen W-C, Wu H-N. 2015. Characterization of the activity of 2&#x2032;-C-methylcytidine against dengue virus replication. Antiviral Res 116:1&#x2013;9. doi:10.1016/j.antiviral.2015.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.01.002</ArticleId><ArticleId IdType="pubmed">25614455</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R-F, Liu J-W, Yeh W-T, Wang L, Chang J-C, Yu H-R, Cheng J-T, Yang KD. 2005. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 44:43&#x2013;50. doi:10.1016/j.femsim.2004.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.femsim.2004.11.012</ArticleId><ArticleId IdType="pubmed">15780577</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L-C, Lei H-Y, Liu C-C, Shiesh S-C, Chen S-H, Liu H-S, Lin Y-S, Wang S-T, Shyu H-W, Yeh T-M. 2006. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 74:142&#x2013;147. doi:10.4269/ajtmh.2006.74.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2006.74.142</ArticleId><ArticleId IdType="pubmed">16407359</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, Bozza PT, Kubelka CF. 2008. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8:86. doi:10.1186/1471-2334-8-86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-8-86</ArticleId><ArticleId IdType="pmc">PMC2474613</ArticleId><ArticleId IdType="pubmed">18578883</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C-C, Tsai M-H, Hu H-S, Pu S-Y, Wu R-H, Wu S-H, Lin H-M, Song J-S, Chao Y-S, Yueh A. 2013. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus. Antiviral Res 98:228&#x2013;241. doi:10.1016/j.antiviral.2013.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.03.001</ArticleId><ArticleId IdType="pubmed">23499649</ArticleId></ArticleIdList></Reference><Reference><Citation>Low JG, Ooi E, Tolfvenstam T, Leo Y-S, Hibberd ML, Ng L-C, Lai Y-L, Yap G, Li C, Vasudevan SG. 2006. Early dengue infection and outcome study (EDEN): study design and preliminary findings. Ann Acad Med Singapore 35:783&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">17160194</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi K, Teoh B-T, Sam S-S, Wong P-F, Mustafa MR, AbuBakar S. 2012. Novel antiviral activity of baicalein against dengue virus. BMC Complement Altern Med 12:214. doi:10.1186/1472-6882-12-214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6882-12-214</ArticleId><ArticleId IdType="pmc">PMC3528482</ArticleId><ArticleId IdType="pubmed">23140177</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Zhang H, Tao S, Ehteshami M, Cho JH, McBrayer TR, Tharnish P, Whitaker T, Amblard F, Coats SJ, Schinazi RF. 2016. Synthesis and evaluation of 2,6-modified purine 2&#x2032;-C-methyl ribonucleosides as inhibitors of HCV replication. ACS Med Chem Lett 7:17&#x2013;22. doi:10.1021/acsmedchemlett.5b00402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsmedchemlett.5b00402</ArticleId><ArticleId IdType="pmc">PMC4716611</ArticleId><ArticleId IdType="pubmed">26819659</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldrup AB, Prhavc M, Brooks J, Bhat B, Prakash TP, Song Q, Bera S, Bhat N, Dande P, Cook PD, Bennett CF, Carroll SS, Ball RG, Bosserman M, Burlein C, Colwell LF, Fay JF, Flores OA, Getty K, LaFemina RL, Leone J, MacCoss M, McMasters DR, Tomassini JE, Von Langen D, Wolanski B, Olsen DB. 2004. Structure-activity relationship of heterobase-modified 2&#x2032;-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication. J Med Chem 47:5284&#x2013;5297. doi:10.1021/jm040068f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm040068f</ArticleId><ArticleId IdType="pubmed">15456273</ArticleId></ArticleIdList></Reference><Reference><Citation>Sari O, Bassit L, Gavegnano C, McBrayer TR, McCormick L, Cox B, Coats SJ, Amblard F, Schinazi RF. 2017. Synthesis and antiviral evaluation of 2&#x2032;,2&#x2032;,3&#x2032;,3&#x2032;-tetrafluoro nucleoside analogs. Tetrahedron Lett 58:642&#x2013;644. doi:10.1016/j.tetlet.2017.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tetlet.2017.01.006</ArticleId><ArticleId IdType="pmc">PMC5289701</ArticleId><ArticleId IdType="pubmed">28163339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatton W, Hunault J, Egorov M, Len C, Pipelier M, Blot V, Silvestre V, Fargeas V, An&#xe9; A, McBrayer T, Detorio M, Cho J-H, Bourgougnon N, Dubreuil D, Schinazi RF, Lebreton J. 2011. Synthesis and biological evaluation of 4&#x2032;&#x2010;C,3&#x2032;&#x2010;O&#x2010;propylene&#x2010;linked bicyclic nucleosides. Eur J Org Chem 2011:7390&#x2013;7399. doi:10.1002/ejoc.201100859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejoc.201100859</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DB, Kalayanov G, Sund C, Winqvist A, Maltseva T, Leveque VJ-P, Rajyaguru S, Pogam SL, Najera I, Benkestock K, Zhou X-X, Kaiser AC, Maag H, Cammack N, Martin JA, Swallow S, Johansson NG, Klumpp K, Smith M. 2009. The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4&#x2032;-azidocytidine against hepatitis C virus replication: the discovery of 4&#x2032;-azido-2&#x2032;-deoxy-2&#x2032;-fluorocytidine and 4&#x2032;-azido-2&#x2032;-dideoxy-2&#x2032;, 2&#x2032;-difluorocytidine. J Med Chem 52:2971&#x2013;2978. doi:10.1021/jm801595c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm801595c</ArticleId><ArticleId IdType="pubmed">19341305</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofia MJ, Bao D, Chang W, Du J, Nagarathnam D, Rachakonda S, Reddy PG, Ross BS, Wang P, Zhang H-R, Bansal S, Espiritu C, Keilman M, Lam AM, Steuer HMM, Niu C, Otto MJ, Furman PA. 2010. Discovery of a &#x3b2;-d-2&#x2032;-deoxy-2&#x2032;-&#x3b1;-fluoro-2&#x2032;-&#x3b2;-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. J Med Chem 53:7202&#x2013;7218. doi:10.1021/jm100863x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm100863x</ArticleId><ArticleId IdType="pubmed">20845908</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghaddam E, Teoh B-T, Sam S-S, Lani R, Hassandarvish P, Chik Z, Yueh A, Abubakar S, Zandi K. 2014. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci Rep 4:5452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071309</ArticleId><ArticleId IdType="pubmed">24965553</ArticleId></ArticleIdList></Reference><Reference><Citation>Johari J, Kianmehr A, Mustafa MR, Abubakar S, Zandi K. 2012. Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus. Int J Mol Sci 13:16785&#x2013;16795. doi:10.3390/ijms131216785.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms131216785</ArticleId><ArticleId IdType="pmc">PMC3546721</ArticleId><ArticleId IdType="pubmed">23222683</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhosh SR, Parida MM, Dash PK, Pateriya A, Pattnaik B, Pradhan HK, Tripathi NK, Ambuj S, Gupta N, Saxena P, Lakshmana Rao PV. 2007. Development and evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantification of chikungunya virus. J Clin Virol 39:188&#x2013;193. doi:10.1016/j.jcv.2007.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2007.04.015</ArticleId><ArticleId IdType="pubmed">17553740</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S-I, Park D-H, Saif LJ, Jeong Y-J, Shin D-J, Chun Y-H, Park S-J, Kim H-J, Hosmillo M, Kwon H-J, Kang M-I, Cho K-O. 2009. Development of SYBR Green real-time RT-PCR for rapid detection, quantitation and diagnosis of unclassified bovine enteric calicivirus. J Virol Methods 159:64&#x2013;68. doi:10.1016/j.jviromet.2009.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2009.03.001</ArticleId><ArticleId IdType="pmc">PMC7119535</ArticleId><ArticleId IdType="pubmed">19442847</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. J Mol Graph 14:33&#x2013;38. doi:10.1016/0263-7855(96)00018-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0263-7855(96)00018-5</ArticleId><ArticleId IdType="pubmed">8744570</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa VV, Fagundes CT, Valad&#xe3;o DF, &#xc1;vila TV, Cisalpino D, Rocha RF, Ribeiro LS, Ascen&#xe7;&#xe3;o FR, Kangussu LM, Junior CMQ, Astigarraga RG, Gouveia FL, Silva TA, Bonaventura D, de Almeida Sampaio D, Leite ACL, Teixeira MM, Souza DG. 2014. Subversion of early innate antiviral responses during antibody-dependent enhancement of dengue virus infection induces severe disease in immunocompetent mice. Med Microbiol Immunol 203:231&#x2013;250. doi:10.1007/s00430-014-0334-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-014-0334-5</ArticleId><ArticleId IdType="pubmed">24723052</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>